These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9816691)

  • 1. [Use of new thrombin inhibitors in medical practice].
    Blaya C; Prati C; Boneti C; Bonamigo DR; Krumenauer RC; Rosito GA
    Arq Bras Cardiol; 1998 Aug; 71(2):163-7. PubMed ID: 9816691
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential advantages of direct-acting thrombin inhibitors.
    Philippides GJ; Loscalzo J
    Coron Artery Dis; 1996 Jul; 7(7):497-507. PubMed ID: 8913677
    [No Abstract]   [Full Text] [Related]  

  • 3. Specific thrombin inhibitors in vivo.
    Fitzgerald D
    Ann N Y Acad Sci; 1994 Apr; 714():41-52. PubMed ID: 8017791
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombin inhibitors in acute coronary artery disease.
    Vorchheimer DA; Fuster V
    Eur Heart J; 2002 Aug; 23(15):1142-4. PubMed ID: 12127916
    [No Abstract]   [Full Text] [Related]  

  • 5. Coronary thrombolysis, conjunctive heparin infusion, and the effect on systemic thrombin activity.
    Garabedian HD; Gold HK
    Circulation; 1992 Mar; 85(3):1205-7. PubMed ID: 1537116
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antithrombin therapy in acute coronary syndromes].
    Maseri A; Andreotti F; Biasucci LM; Rebuzzi AG
    Cardiologia; 1994 Dec; 39(12 Suppl 1):7-13. PubMed ID: 7634317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New thrombin inhibiting strategies for coronary artery disease.
    Shah PK; Parikh A
    Indian Heart J; 1995; 47(4):381-6. PubMed ID: 8557285
    [No Abstract]   [Full Text] [Related]  

  • 8. [Direct thrombin inhibitors].
    Bornkessel B
    Med Monatsschr Pharm; 1997 Apr; 20(4):86-9. PubMed ID: 9198724
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
    Leadley RJ; Kasiewski CJ; Bostwick JS; Bentley R; McVey MJ; White FJ; Perrone MH; Dunwiddie CT
    Thromb Haemost; 1997 Oct; 78(4):1278-85. PubMed ID: 9364998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is thrombin a pharmacological target during reperfusion?
    White HD
    Blood Coagul Fibrinolysis; 1999 Feb; 10 Suppl 1():S55-7. PubMed ID: 10070820
    [No Abstract]   [Full Text] [Related]  

  • 11. Anticoagulant therapy for percutaneous coronary intervention.
    Rao SV; Ohman EM
    Circ Cardiovasc Interv; 2010 Feb; 3(1):80-8. PubMed ID: 20160186
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mechanism of thrombosis: physiopathology, role of thrombin and its inhibition by modern therapies].
    Hamon M
    Arch Mal Coeur Vaiss; 2006 Feb; 99 Spec no.3():5-9. PubMed ID: 16553237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enoxaparin vs unfractionated heparin in acute coronary syndrome.
    Pedrini M; Hartig F; Pechlaner C
    JAMA; 2004 Oct; 292(16):1952; author reply 1952-3. PubMed ID: 15507578
    [No Abstract]   [Full Text] [Related]  

  • 14. Enoxaparin vs unfractionated heparin in acute coronary syndrome.
    Kanna B; Sharma P
    JAMA; 2004 Oct; 292(16):1952; author reply 1953. PubMed ID: 15507577
    [No Abstract]   [Full Text] [Related]  

  • 15. Direct thrombin inhibitors (part 2 of 2).
    Arora UK; Dhir M
    J Invasive Cardiol; 2005 Feb; 17(2):85-91. PubMed ID: 15687531
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjunctive use of direct thrombin inhibitors in patients receiving fibrinolytic therapy for acute myocardial infarction.
    French JK; Edmond JJ; Gao W; White HD; Eikelboom JW
    Am J Cardiovasc Drugs; 2004; 4(2):107-15. PubMed ID: 15049722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current issues in management of thromboses.
    Clark S
    Lancet; 1995 Jul; 346(8967):113-4. PubMed ID: 7603184
    [No Abstract]   [Full Text] [Related]  

  • 18. Direct thrombin inhibitors for non-ST-segment elevation acute coronary syndromes: what, when, and where?
    Lincoff AM
    Am Heart J; 2003 Oct; 146(4 Suppl):S23-30. PubMed ID: 14564303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulation for acute coronary syndromes: from heparin to direct thrombin inhibitors.
    Lepor NE
    Rev Cardiovasc Med; 2007; 8 Suppl 3():S9-17. PubMed ID: 17917621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current role of antithrombotic agents in the treatment of acute coronary syndromes.
    Mukherjee D; Bates ER
    Semin Thromb Hemost; 2004 Dec; 30(6):627-32. PubMed ID: 15630668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.